916
Views
61
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Toxicological and epidemiological studies on effects of airborne fibers: Coherence and public health implications

Pages 643-695 | Received 21 Jan 2014, Accepted 22 May 2014, Published online: 29 Aug 2014

References

  • ACGIH-AIHA Aerosol Hazards Evaluation Committee. (1975). Recommended procedures for sampling and counting asbestos fibers. Am Ind Hyg Assoc J, 36, 83–90.
  • Adamson IYR. (1997). Early mesothelial cell proliferation after asbestos exposure: In vivo and in vitro studies. Environ Health Perspect, 105, 1205–8.
  • Albin M, Pooley FD, Strömberg U, Atteweil U, Mitha R, Johansson L, Welinder H. (1994). Retention patterns of asbestos fibers in lung tissue among asbestos cement workers. Occup Environ Med, 51, 205–11.
  • Alexander BH, Raleigh KK, Johnson J, Mandel JH, Adgate JL, Ramachandran G, et al. (2012). Radiographic evidence of nonoccupational asbestos exposure from processing Libby vermiculite in Minneapolis, MN. Environ Health Perspect, 120, 44–9.
  • Allison AC. (1977). Mechanisms of macrophage damage in relation to the pathogenesis of some lung diseases. In: Brain JD, Proctor DF, Reid LM, Eds. Respiratory Defense Mechanisms Part II New York: Marcel Dekker, pp. 1075–102.
  • Armstrong BK, de Klerk NH, Musk AW, Hobbs MST. (1988). Mortality in miners and millers of crocidolite in Western Australia. Br J Ind Med, 45, 5–13.
  • Ashcroft T, Simpson JM, Timbrell V. (1988). Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol, 41, 467–70.
  • ATSDR. (2004). Toxicological Profile for Synthetic Vitreous Fibers. Atlanta, Georgia: Agency for Toxic Substances and Disease Registry
  • Balashazy I, Moustafa M, Hofmann W, Szoke R, El-Hussein A, Ahmed A-R. (2005). Simulation of fiber deposition in bronchial airways. Inhal Toxicol, 17, 717–27.
  • Barbieri PG, Mirabelli D, Somigliana A, Cavone D, Merler E. (2012). Asbestos fibre burden in the lungs of patients with mesothelioma who lived near asbestos-cement factories. Ann Occup Hyg, 56, 660–70.
  • Baris YI, Artvinli M, Sahin AA, Sebastien P, Gaudichet A. (1987). Diffuse lung fibrosis due to fibrous zeolite (erionite). Eur J Respir Dis, 70, 122–5.
  • Baris YI, Saracci R, Simonato L, Skidmore JW, Artvinli M. (1981). Malignant melanoma and radiological chest abnormalities in two villages in Central Turkey: an epidemiological and environmental investigation. Lancet, 1, 984–7.
  • Baris YI, Simonato L, Artvinli M, Pooley F, Saracci S, Skidmore J, Wagner C. (1987). Epidemiological and environmental evidence of the health effects of exposure to erionite fibers: A four-year study in the Cappadocian region of Turkey. Int J Cancer, 39, 10–17.
  • Baris YI, Grandjean P. (2006). Prospective study of mesothelioma mortality in Turkish villages with exposure to fibrous zeolite. J Natl Cancer Inst, 98, 414–7.
  • Barrett JC, Lamb PW, Wisemen RW. (1989). Multiple mechanisms for the carcinogenic effects of asbestos and other mineral fibers. Environ Health Perspect, 81, 81–9.
  • Bauman MD, Jetten AM, Bonner JC, Kumar RK, Bennett RA, Brody AR. (1990). Secretion of a platelet-derived growth factor homologue but rat alveolar macrophages exposed to particulates in vitro. Eur J Cell Biol, 51, 327–34.
  • Beck EG, Bruch J, Friedricks KH, Hilscher W, Pott F. (1971). Fibrous silicates in animal experiments and cell-culture in morphological cell and tissue reactions according to different physical chemical influences. In: Walton WH, Ed. Inhaled Particles III, Old Woking, UK: Unwin Bros, pp. 477–86.
  • Begin R, Gauthier JJ, Desmeules M, Ostiguy G. (1992). Work-related mesothelioma in Quebec, 1967–1990. Am J Ind Med, 22, 531–42.
  • Bellmann B, Konig H, Muhle H, Pott H. (1986). Chemical durability of asbestos and of man-made mineral fibres in vivo. J Aerosol Sci, 17, 341–5.
  • Bellmann B, Muhle H, Pott H, Konig H, Kloppel H, Spurny K. (1987). Persistence of man-made mineral fibers (MMMF) and asbestos in rat lungs. Ann Occup Hyg, 31, 693–709.
  • Bellmann B, Muhle H, Creutzenberg O, Ernst H, Brown RC, Sébastien P. (2001). Effects of nonfibrous particles on ceramic fiber (RCF1) toxicity in rats. Inhal Toxicol, 13, 877–901.
  • Berman W, Chatfield EJ. (1989). Interim Superfund Method for the Determination of Asbestos in Ambient Air. Part II: Technical Background Document. Draft Report EPA Contract No. 68-61-7290, Task 117, USEPA, Region 9, San Francisco, CA 94105.
  • Berman DW, Crump KS, Chatfield EJ, Davis JMG, Jones AD. (1995). The sizes, shapes, and mineralogy of asbestos structures that induce lung tumors or mesothelioma in AF-HAN rats following inhalation. Risk Anal, 15, 181–95.
  • Berman DW, Crump KS. (2008a). A meta-analysis of airborne asbestos-related risk that addresses fier size and mineral type. Crit Rev Toxicol, 38, 49–73.
  • Berman DW, Crump KS. (2008b). Update on potency factors for asbestos-related lung cancer and mesothelioma. Crit Rev Toxicol, 38, 1–47.
  • Berman DW, Crump KS. (2001). Technical Support Document for a Proposal to Assess Asbestos-Related Risk. Final Draft. Prepared for the U.S. Environmental Protection Agency and the U.S. Department of Transportation. Sept. 4, 2001.
  • Berman DW, Cox LA Jr, Popken DA. (2013). A cautionary tale: The characteristics of two-dimensional distributions and their effects on epidemiological studies employing an ecological design. Crit Rev Toxicol, 43, 1–25.
  • Bernstein DM, Drew RT, Schidlovsky G, Kuschner H. (1984). Pathogenicity of MMMF and the contrasts to natural fibers. In: Biological Effects of Man-Made Mineral Fibers, Vol. 2 Copenhagen: World Health Organization, pp. 169–95.
  • Bernstein DM, Morscheidt C, Grimm H-G, Thevenaz P, Teichert U. (1996). Evaluation of soluble fibers using the inhalation biopersistence, a nine- fiber comparison. Inhal Toxicol, 8, 345–85.
  • Bernstein DM, Riego Sintes JM, Ersboell BK, Kunert J. (2001a). Biopersistence of synthetic mineral fibers as a predictor of chronic inhalation toxicity in rats. Inhal Toxicol, 13, 823–49.
  • Bernstein DM, Riego Sintes JM, Ersboell BK, Kunert J. (2001b). Biopersistence of synthetic mineral fibers as a predictor of chronic intraperitoneal injection tumor response in rats. Inhal Toxicol, 13, 851–75.
  • Bernstein DM, Rogers R, Smith P. (2004). The biopersistence of Brazilian chrysotile asbestos following inhalation. Inhal Toxicol, 16, 745–61.
  • Bernstein DM, Chevalier J, Smith P. (2005a). Comparison of calidria chrysotile asbestos to pure tremolite: final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhal Toxicol, 17, 427–49.
  • Bernstein DM, Rogers R, Smith P. (2005b). The biopersistence of Canadian chrysotile asbestos following inhalation: final results through 1 year after cessation of exposure. Inhal Toxicol, 17, 1–14.
  • Bernstein DM, Rogers R, Sepulveda R, Donaldson K, Schuler D, Gaering S, et al. (2010). The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure: interim results. Inhal Toxicol, 22, 937–62.
  • Bernstein DM, Rogers R, Sepulveda R, Donaldson K, Schuler D, Gaering S, et al. (2011). Quantitation of the pathological response and fate in the lung and pleura in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure. Inhal Toxicol, 23, 371–91.
  • Bernstein DM, Dunnigan J, Hesterberg T, Brown R, Velasco JAL, Barrera R, et al. (2013). Health risk of chrysotile revisited. Crit Rev Toxicol, 43, 154–83.
  • Berrigan D. (2002). Respiratory cancer and exposure to man-made vitreous fibers: a systematic review. Am J Indust Med, 42, 362.
  • Berry J, Newhouse M. (1983). Mortality of workers manufacturing friction materials using asbestos. Br J Ind Med, 40, 1–7.
  • Berry M. (1997). Mesothelioma incidence and community asbestos exposure. Environ Res, 75, 34–40.
  • Boffetta P, Donaldson K, Moolgavkar S, Mandel J. (2014). A systematic review of occupational exposure to synthetic vitreous fibers and risk of mesothekioma. Crit Rev Toxicol, 44, 436–49.
  • Bolton RE, Vincent JH, Jones AD, Addison J, Beckett ST. (1983). An overload hypothesis for pulmonary clearance of UICC amosite fibers inhaled by rats. Br J Ind Med, 40, 264–72.
  • Borow M, Conston A, Livornese L, Schalet N. (1973). Mesothelioma following exposure to asbestos: a review of 72 cases. Chest, 64, 641–7.
  • Bourdès V, Boffetta P, Pisani P. (2000). Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol, 16, 411–7.
  • Boutin C, Dumortier P, Rey F, Viallat JR, DeVuyst P. (1996). Black spots concentrate oncogenic asbestos fibers in the parietal pleura: thorascopic and mineralogic study. Am J Respir Crit Care Med, 153, 444–9.
  • Briant JK. (1988). Distinction of Reversible and Irreversible Convection by High-frequency Ventilation of a Respiratory Airway Cast. Ph.D. Thesis, New York University.
  • Brody AR, Roe MW. (1983). Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice. Am Rev Respir Dis, 128, 724–9.
  • Brody AR, Hill LH, Adkins B Jr, O’Connor RW. (1981). Chrysotile asbestos inhalation in rats: deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis, 123, 670–9.
  • Buchanich JM, Marsh GM, Youk AO. (2001). Historical cohort study of US man-made vitreous fiber production workers: V. Tobacco smoking habits. J Occup Environ Med, 43, 793–802.
  • Burdett G. (1985). Use of a membrane filter, direct-transfer technique for monitoring environmental asbestos releases. In: A Workshop on Asbestos Fiber Measurements in Building Atmospheres. Mississauga, Ontario: Ontario Research Foundation.
  • Camus M, Siemiatycki J, Meek B. (1998). Nonoccupational exposure to chrysotile asbestos and the risk of lung cancer. N Engl J Med, 338, 1565–71.
  • Carbone M, Emri S, Dogan AU, Steele I, Tuncer M, Pass HI, Baris YI. (2007). A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes. Natl Rev Cancer, 7, 147–54.
  • Case BW, Dufresne A, McDonald AD, McDonald JC, Sébastien P. (2000). Asbestos fiber type and length in lungs of chrysotile textile and production workers: fibers longer than 18μm. Inhal Toxicol, 12, 411–8.
  • Case BW, Camus M, Richardson L, Parent ME, Desy M, Siemiatycki J. (2002). Preliminary findings for pleural mesothelioma among women in the Quebec chrysotile mining regions. Ann Occup Hyg, 46, 128–31.
  • Case BW, Abraham JL. (2009). Heterogeneity of exposure and attribution of mesothelioma: trends and strategies in two American counties. J Phys Conf Ser, 151:012008.
  • Case BW, Abraham JL, Meeker G, Pooley FD, Pinkerton KE. (2011). Applying definitions of “Asbestos” to environmental and “Low-Dose” exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health Part B, 14, 3–39.
  • Casey KR, Shigeoka JW, Rom WN, Moatamed F. (1985). Zeolite exposure and associated pneumoconiosis. Chest, 87, 837–40.
  • Chan TL, Lee PS, Hering WE. (1984). Pulmonary retention of inhaled diesel particles after prolonged exposures to diesel exhaust. Fundam Appl Toxicol, 4, 624–31.
  • Cherrie J, Dodgson J, Groat S, MacLaren W. (1986). Environmental surveys in the European man-made mineral fiber production industry. Scand. J Work Environ Health, 12, 18–25.
  • Chisholm JE. (1983). Transmission electron microscopy of asbestos. In: Chissick SS, Derricott R, Eds. Asbestos. Chichester: John Wiley & Sons, pp. 86–167.
  • Churg A. (1988). Chrysotile, tremolite, and malignant mesothelioma in man. Chest, 93, 621–8.
  • Churg A. (1994). Deposition and clearance of chrysotile asbestos. Ann Occup Hyg, 38, 625–33.
  • Churg A, Wiggs B. (1987). Accumulation of long asbestos fibers in the peripheral upper lobe in cases of malignant mesothelioma. Am J Ind Med, 11, 563–9.
  • Churg A, Wiggs B, Depaoli L, Kampe B, Stevens B. (1984). Lung asbestos content in chrysotile workers with mesothelioma. Am Rev Respir Dis, 130, 1042–5.
  • Churg A, Wright J, Gilks B, Dai J. (2000). Pathogenesis of fibrosis produced by asbestos and man-made mineral fibers: what makes a fiber fibrogenic? Inhal Toxicol, 12, 15–26.
  • Collier CG, Morris KJ, Launder KA, Humphreys JA, Morgan A, Eastes W, Townsend S. (1994). The behavior of glass fibers in the rat following intraperitoneal injection. Regul Toxicol Pharmacol, 20, S89–103.
  • Collier CG, Morris KJ, Launder KA, Humphreys JA, Morgan A, Eastes W, Townsend S. (1995). The durability and distribution of glass fibres in the rat following intra-peritoneal injection. Ann Occup Hyg, 39, 699–704.
  • Collier CG, Kamstrup O, Morris KJ, Applin RA, Vatter IA. (1997). Lung clearance of experimental man-made mineral fibres, preliminary data on the effect of fiber length. Ann Occup Hyg, 41, 320–6.
  • Cooke WE. (1927). Pulmonary asbestosis. Brit Med J, 2, 1024.
  • Cox LA, Popken DA, Berman DW. (2013). Causal versus spurious spatial exposure-response associations in health risk analysis. Crit Rev Toxicol, 43, 26–38.
  • Craighead JE. (1987). Current pathogenetic concepts of diffuse malignant mesothelioma. Human Pathol, 18, 544–57.
  • Cullen RT, Searl A, Buchanan D, Davis JMG, Miller BG, Jones AD. (2000). Pathogenicity of a special-purpose glass microfiber (E glass) relative to another glass microfiber and amosite asbestos. Inhal Toxicol, 12, 959–77.
  • Davis JMG. (1976). Pathological aspects of the injection of fiber into the pleural and peritoneal cavities of rats and mice. In: Occupational Exposure to Fibrous Glass, HEW Publ. No. (NIOSH) 76–151, Washington, DC: DHEW, pp. 141–99.
  • Davis JMG, Beckett ST, Bolton RE, Collings P, Middleton AP. (1978). Mass and number of fibers in the pathogenesis of asbestos-related lung disease in rats. Br J Cancer, 37, 673–88.
  • Davis JMG, Addison J, Bolton RE, Donaldson K, Jones AD, Miller BG. (1985). Inhalation studies on the effects of tremolite and brucite dust in rats. Carcinogenesis, 6, 667–74.
  • Davis JMG, Addison J, Bolton RE, Donaldson K, Jones AD, Smith T. (1986a). The pathogenicity of long versus short fiber samples of amosite asbestos administered to rats by inhalation and intraperitoneal injection. Br J Exp Pathol, 67, 415–30.
  • Davis JMG, Addison J, Bolton R, Donaldson K, Jones AD. (1986b). Inhalation and injection studies in rats using dust samples from chrysotile asbestos prepared by a wet dispersion process. Brit J Pathol, 67, 113–29.
  • Davis JMG. (1987). Experimental data relating to the importance of fibre type, size, deposition, dissolution and migration. In: Proceedings of 1987 Mineral Fiber Symposium, Lyons, IARC.
  • Davis JMG, Jones AD. (1988). Comparisons of the pathogenicity of long and short fibres of chrysotile asbestos in rats. Br J Exp Pathol, 69, 717–37.
  • Davis JMG, Addison J, McIntosh C, Miller BG, Niven K. (1991). Variations in the carcinogenicity of tremolite dust samples of differing morphology. Ann NY Acad Sci, 643, 473–90.
  • Davis JMG, Brown DM, Cullen RT, Donaldson K, Jones AD, Miller BG, et al. (1996). A comparison of methods of determining and predicting the pathogenicity of mineral fibers. Inhal Toxicol, 8, 747–70.
  • De Klerk NH, Armstrong BK, Musk AW, Hobbs MST. (1989). Cancer mortality in relation to measures of occupational exposure to crocidolite at Wittenoom Gorge in Western Australia. Br J Ind Med, 46, 529–36.
  • deKlerk NH, Musk AW, Glancy JJ, Pang PS, Lund HG, Olsen N, Hobbs MST. (1997). Crocidolite, radiographic asbestosis and subsequent lung cancer. Ann Occup Hyg, 41, 134–6.
  • Dement JM, Harris RL, Symans MJ, Shy C. (1982). Estimates of dose-response for respiratory cancer among chrysotile asbestosis workers. Ann Occup Hyg, 28, 869–87.
  • Dement JM, Harris RL Jr, Symans MR, Shy CM. (1983). Exposures and mortality among chrysotile asbestos workers. Part II: Mortality. Am JInd Med, 4, 421–33.
  • Dement JM, Brown DP, Okun A. (1994). Follow-up study of chrysotile asbestos textile workers: Cohort mortality and case-control analyses. Am J Ind Med, 26, 431–47.
  • Dodson RF, Williams MG Jr, Corn CJ, Brollo A, Bianchi A. (1990). Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis, 142, 843–7.
  • Dodson RF, Atkinson MAL, Levin JL. (2003). Asbestos fiber length as related to potential pathogenicity: a critical review. Am J Indust Med, 44, 291–7.
  • Doll R. (1955). Mortality from lung cancer in asbestos workers. Br J Industr Med, 12, 81–6.
  • Doll R, Peto J. (1985). Effects on Health of Exposure to Asbestos. A Report of the Health and Safety Commission. London: Her Majesty’s Stationery Office.
  • Doll R. (1987). Symposium on MMMF, Copenhagen, October 1986: overview and conclusions. Ann Occup Hyg, 31, 805–19.
  • Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A. (2006). Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci, 92, 5–22.
  • Donaldson K. (2009). The inhalation toxicology of p-aramid fibrils. Crit Rev Toxicol, 39, 487–500.
  • Donaldson K, Murphy FA, Duffin R, Poland CA. (2010). Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Partic Fibre Toxicol, 7, 5–22.
  • Dufresne A, Bégin R, Masse S, Dufresne CM, Loosereewanich P, Perrault G. (1996). Retention of asbestos fibres in lungs of workers with asbestosis, asbestosis and lung cancer, and mesothelioma in Asbestos township. Occup Environ Med, 53, 801–7.
  • Dunning KK, Adjei S, Levin L, Hilbert T, Borton E, Kapil V, et al. (2012). Mesothelioma associated with commercial use of vermiculite containing Libby amphibole. J Occup Environ Med, 54, 1359–63.
  • Eastes W, Hadley JG. (1995). Dissolution of fibers inhaled by rats. Inhal Toxicol, 7, 179–96.
  • Ellman P. (1933). Pulmonary asbestosis: its clinical, radiological, and pathological features, and associated risk of tuberculosis infection. J Industr Hyg, 25, 165–83.
  • Engholm G, Englund A, Fletcher CC, Hallin N. (1987). Respiratory cancer incidence in Swedish construction workers exposed to man-made mineral fibers and asbestos. Ann Occup Hyg, 31, 663–75.
  • Enterline PE, Marsh GM, Esmen NA. (1983). Respiratory disease among workers exposed to man-made mineral fibers. Am Rev Respir Dis, 128, 1–7.
  • Enterline PE, Marsh GM, Henderson V, Callahan C. (1987). Mortality update of a cohort of U.S. man-made mineral fiber workers. Ann Occup Hyg, 31, 625–56.
  • EPA. (1996). Proposed Guidelines for Carcinogen Risk Assessment. EPA/600/P-92/003C. U.S. Government Printing Office, Washington, DC. April 1996.
  • EPA-SAB. (2013). Review of EPA's draft assessment entitled: Toxicological Review of Libby Amphibole Asbestos. EPA-SAB-13-001.
  • ERG. (2003a). Report on the Peer Consultation Workshop to Discuss a Proposed Protocol to Assess Asbestos Related Risk. Eastern Research Group, Inc., Lexington MA. May 30, 2003.
  • ERG. (2003b). Report on the Expert Panel on Health Effects of Asbestos and Synthetic Vitreous Fibers in the Influence of Fiber Length. Eastern Research Group, Inc., Lexington MA. March 17, 2003.
  • Esmen NA. (1984). Short-term survey of airborne fibres in U.S. manufacturing plants. In: Biological Effects of Man-Made Mineral Fibers, Vol. 1. Copenhagen: WHO-EURO, pp. 65–82.
  • Esmen NA, Erdal S. (1990). Human occupational and nonoccupational exposure to fibers. Environ Health Perspect, 88, 277–86.
  • Ferin J. (1972). Observations concerning alveolar dust clearance. Ann NY Acad Sci, 200, 66–72.
  • Ferin J, Leach LJ. (1976). The effect of amosite and chrysotile asbestos on the clearance of TiO2 particles from the lung. Environ Res, 12, 250–4.
  • Finkelstein MM. (1983). Mortality among long-term employees of an Ontario asbestos-cement factory. Br J Ind Med, 40, 138–44.
  • Floyd RA. (1990). Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J, 4, 2587–97.
  • Forster H. (1984). The behavior of mineral fibers in physiological solutions. In: Biological Effects of Man-Made Mineral Fibers, Vol. 2 Copenhagen: World Health Organization, pp. 27–59.
  • Frank AL, Dodson RF, Williams MG. (1997). Lack of tremolite in UICC reference chrysotile and the implications for carcinogenicity. Ann Occup Hyg, 41, 287–92.
  • Gentry JW, Spurny KR, Schormann J, Opiela H. (1983). Measurement of the diffusion coefficient of asbestos fibers. In: Marple VA, Liu BYH, Eds. Aerosols in the Mining and Industrial Work Environments, Vol. 2 Ann Arbor: Ann Arbor Science Publishers, pp. 593–612.
  • Gibbs GW. (1979). Etiology of pleural calcification: a study of Quebec asbestos miners and millers. Arch Environ Health, 34, 76–82.
  • Gloyne SR. (1930). The reaction of tissues to the asbestos fibre with reference to pulmonary asbestosis. Tubercle, 11, 151.
  • Gloyne SR. (1951). A historical survey of necroscopy material in 1205 cases. Lancet, April 14, 1951, 810–4.
  • Goodglick LA, Kane AB. (1990). Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res, 50, 5153–63.
  • Griffis LC, Henderson TR, Pickrell JA. (1981). A method for determining glass in rat lung after exposure to a glass fiber aerosol. Am Ind Hyg Assoc J, 42, 566–9.
  • Gurman JL, Lippmann M, Schlesinger RB. (1984a). Particle deposition in replicate casts of the human upper tracheobronchial tree under constant and cyclic inspiratory flow. I. Experimental. Aerosol Sic Technol, 3, 245–52.
  • Gurman JL, Lioy PJ, Lippmann M, Schlesinger RB. (1984b). Particle deposition in replicate casts of the human upper tracheobronchial tree under constant and cyclic inspiratory flow. II. Empirical model. Aerosol Sci Technol, 3, 253–7.
  • Gurman JL, Schlesinger RB, Lippmann M. (1980). A variable-opening mechanical larynx for use in aerosol deposition studies. Am Ind Hyg Assoc J, 41, 678–80.
  • Gylseth B, Mowe B, Wannag A. (1983). Fiber type and concentration in the lungs of workers in an asbestos cement factory. Br J Ind Med, 40, 375–9.
  • Hain E, Dalquen P, Bohlig H, Dabbert A, Hinz I. (1974). Retrospective study of 150 cases of mesothelioma in Hamburg area. Int Arch Argeitsmed, 33, 15–37.
  • Hammad YY. (1984). Deposition and elimination of MMMF. In: Biological Effects of Man-Made Mineral Fibers, Vol. 2. Copenhagen: World Health Organization, pp. 126–42.
  • Hammond EC, Garfinkle L, Selikoff IT, Nicholson WJ. (1979). Mortality experience of residents in the neighborhood of an asbestos factory. Ann NY Acad Sci, 330, 417–22.
  • Hamra GB, Loomis D, Dement J. (2014). Examining the association of lung cancer and highly correlated fibre size-specific asbestos exposures with a hierarchical model. Occup Environ Med. (online Feb. 24, 2014). doi:10.1136/oemed-2013–101965.
  • Hansen J, deKlerk NH, Musk AW, Eccles JL, Hobbs MST. (1997). Mesothelioma after environmental crocidolite exposure. Ann Occup Hyg, 41, 189–193.
  • Harington JS. (1981). Fiber carcinogenesis: epidemiologic observations and the Stanton hypothesis. J Natl Cancer Inst, 67, 977–89.
  • HEI-AR. (1991). Health Effects Institute-Asbestos Research. Report of Literature Review Panel, Cambridge, MA.
  • Hesterberg TW, Miller WC, McConnell EE, Chevalier J, Hadley J, Bernstein D, et al. (1993). Chronic inhalation toxicity of size-separated glass fibers in Fisher 344 rats. Fundam Appl Toxicol, 20, 464–76.
  • Hesterberg TW, Chase G, Axten C, Miller WC, Musselman RP, Kamstrup O, et al. (1998a). Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol, 151, 262–75.
  • Hesterberg TW, Hart GA, Chevalier J, Miller WC, Bauer J, Thevenaz P. (1998b). The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats. Toxicol Appl Pharmacol, 153, 68–82.
  • Hesterberg TW, Hart GA. (2001). Synthetic vitreous fibers: a review of toxicology research and its impact on hazard classification. Crit Rev Toxicol, 31, 1–53.
  • Hesterberg TW, Anderson R, Bernstein DM, Bunn WB, Chase GA, Janukouski AL, et al. (2012). Product stewardship and science: safe manufacture and use of fiber glass. Reg Toxicol Pharmacol, 62, 257–77.
  • Hiett DM. (1978). Experimentak asbestosis: An investigation of functional and pathological disturbances. Br J Ind Med, 35, 129–145.
  • Hillegass JM, Miller JM, MacPherson MB, Westbom CM, Sayan M, Thompson JK, et al. (2013). Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. Particle Fibre Toxicol, 10, 3948.
  • Hodgson JT, Darnton A. (2000). The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg, 44, 565–601.
  • Hoffman FI. (1918). Mortality and respiratory diseases in dusty trades (Inorganic dusts). U.S. Bur. Lab. Stat. No. Bulletin, 231, 176–80.
  • Holt PR. (1982). Translocation of asbestos dust through the bronchiolar wall. Environ Res, 27, 255–60.
  • Hook HL, Morrice G Jr, deTreville RT. (1970). Fiberglass manufacturing and health: results of a comprehensive physiological study. Proceedings of the 35th Annual Meeting of the Industrial Health Foundation. October 13–14, 1970. Pittsburgh, PA. IHF Bulletin No. 44. 103–111.
  • Hughes JM, Jones RN, Glindmeyer HW, Hammad YY, Weill H. (1993). Follow up study of workers exposed to man made mineral fibres. Br J Ind Med, 50, 658–67.
  • IARC. (2002). IARC Monographs on the Evaluation of Carcinogenic Risks to Human: Volume 81:1–381. – Man-Made Vitreous Fibres. World Health Organization. International Agency for Research on Cancer. Geneva: IARC Press.
  • ISO. (1993). International Standard (ISO 8762): Air Quality – Determination of the number concentration of airborne inorganic fibres by phase contrast optical microscopy – membrane filter method. International Organization for Standardization CH-1211, Geneve 20, Switzerland, 25pp.
  • Johnson NF, Griffiths DM, Hill RJ. (1984). Size distributions following long-term inhalation of MMMF. In: Biological Effects of Man-Made Mineral Fibers, Vol. 2 Copenhagen: World Health Organization, pp. 102–25.
  • Jones AD, Johnston AM, Vincent JH. (1983). Static electrification of airborne asbestos dust. In: Marple VA, Liu BYH, Eds. Aerosols in the Mining and Industrial Work Environments, Vol. 2 Ann Arbor: Ann Arbor Science Publishers, pp. 613–22.
  • Jones AD, McMillan CH, Johnston AM, McIntosh C, Cowie H, Bolton RE, et al. (1988). Pulmonary clearance of UICC amosite fibers inhaled by rats during chronic exposure at low concentration. Br J Ind Med, 45, 300–4.
  • Jones JSP, Pooley FD, Sawle GW, Madeley RJ, Smith PG, Berry G, et al. (1980). The consequences of exposure to asbestos dust in a wartime gas-mask factory. In: Wagner JC, Ed. Biological Effects of Mineral Fibres, IARC Scientific Pub. No. 30, Vol. 2 Lyons: International Agency for Research on Cancer, pp. 637–53.
  • Kamstrup O, Davis JMG, Ellehauge A, Goldberg M. (1998). The biopersistence and pathogenicity of man-made vitreous fibers after short- and long-term inhalation. Ann Occup Hyg, 42, 191–9.
  • Kane AB, McDonald JL. (1993). Mechanisms of mesothelial cell injury, proliferation and neoplasia induced by asbestos fibers. In: Warheit DB, Ed. Fiber Toxicology: Contemporary Issues. Academic Press, pp. 323–47.
  • King EJ, Clegg JW, Rae VM. (1946). The effect of asbestos, and of asbestos and aluminum, on the lung of rabbits. Thorax, 1, 188–97.
  • Kjærheim K, Boffetta P, Hansen J, Cherrie J, Chang-Claude J, Eilber U, et al. (2002). Lung cancer among rock and lag wool production workers. Epidemiology, 13, 445–53.
  • Klingholz R, Steinkopf B. (1982). Das Verhalten von Kunstlichen Mineralfasern in einer physiologischen Modellflassigkeit und in Wasser. StaubReinhalt Luft, 42, 69–76.
  • Klingholz R, Steinkopf B. (1984). The reactions of MMMF in a physiological model fluid and in water. In: Biological Effects of Man-Made Mineral Fibers, Vol. 1 Copenhagen: WHO-EURO, pp. 60–86.
  • Konzen JL. (1984). Production trends in fibre sizes of MMMF insulation. In: Biological Effects of Man-Made Mineral Fibers, Vol. 1, Copenhagen: World Health Organization, pp. 44–63.
  • Kurumatani N, Kumagai S. (2008). Mapping the risk of mesothelioma due to neighborhood asbestos exposure. Am J Resp Crit Care Med, 178, 624–9.
  • Lacourt A, Gramond C, Audignon S, Ducamp S, Fevotte J, Ilg AGS, et al. (2013). Pleural mesothelioma and occupational coexposure to asbestos, mineral wool, and silica. Am J Crit Care Med, 187, 977–82.
  • Langer AM, Nolan RP, Addison J. (1990). Physico-chemical properties of asbestos as determinants of biological potential. In: Miller K, Liddle D, Eds. CRC Monograph Asbestos and Disease Boca Raton, FL: CRC Press.
  • Lanza AJ, McConnell WJ, Fehnel W. (1935). Effects of the inhalation of asbestos dust on the lungs of asbestos workers. Publ Health Rep, 50, 1–13.
  • Larson RI. (2003). An air quality data analysis system for interrelating effects, standards, and needed source reductions: Part 13- Applying the EPA Proposed Guidelines for Carcinogen Risk Assessment to a set of asbestos lung cancer mortality data. J Air Waste Manag Assoc, 53, 1226–339.
  • Larson TC, Antao VC, Bove FJ, Cusack C. (2012). Association between cumulative fiber exposure and respiratory outcomes among Libby vermiculite workers. J Occup Environ Med, 54, 56–63.
  • LeBouffant L, Henin JP, Martin JC, Normand C, Tichoux G, Trolard F. (1984). Distribution of inhaled MMMF in the rat lung - long term effects. In: Biological Effects of Man-Made Mineral Fibers, Vol. 2. Copenhagen: World Health Organization, pp. 143–68.
  • Lee KP, Barras CE, Griffith FD, Waritz RS, Lapin CA. (1981). Comparative pulmonary responses to inhaled inorganic fibers with asbestos and fiberglass. Environ Res, 24, 167–91.
  • Lee KP, Kelly DP, Kennedy GL Jr. (1983). Pulmonary response to inhaled Kevlar aramid synthetic fibers in rats. Toxicol Appl Pharmacol, 71, 242–53.
  • LeMasters G, Lockey J. (1994). Radiographic changes among workers manufacturing refractory ceramic fibre and products. Ann Occup Hyg, 38, 745–51.
  • LeMasters GK, Lockey JE, Levin LS, Mckay RT, Rice CH, Horvath EP, et al. (1998). An industry-wide pulmonary study of men and women manufacturing refractory ceramic fibers. Am J Epidemiol, 148, 910–9.
  • LeMasters GK, Lockey JE, Yin JH, Levin LS, Rice CH. (2003). Mortality of workers occupationally exposed to refractory ceramic fibers. J Occup Environ Med, 45, 440–50.
  • Lentz TJ, Rice CH, Succop PA, Lockey JE, Dement JM, LeMasters GK. (2003). Pulmonary deposition modeling with airborne fiber exposure data: a study of workers manufacturing refractory ceramic fibers. App Occup Environ Hyg, 18, 278–88.
  • Levin JL, McLarty JW, Hurst GA, Smith AN, Frank AL. (1998). Tyler asbestos workers: mortality experience in a cohort exposed to amosite. Occup Environ Med, 55, 155–60.
  • Lippmann M. (1988). Asbestos exposure indices. Environ Res, 46, 86–106.
  • Lippmann M. (1990). Man-made mineral fibers (MMMF): Human exposures and health risk assessment. Toxicol Ind Health, 6, 225–46.
  • Lippmann M. (1994). Deposition and retention of fibres: Effects on incidence of lung cancer and mesothelioma. Occup Environ Med, 51, 793–8.
  • Lippmann M. (2003). Letter to the Editor. J Air Waste Manage Assoc, 53, 1298–300.
  • Lippmann M. (2009). Asbestos and other mineral fibers. In: Environmental Toxicants III: Human Exposures and Their Health Effects, 3rd Ed. New York, NY: John Wiley, pp. 395–458.
  • Lippmann M, Timbrell V. (1990). Particle loading in the human lung – Human experience and implications for exposure limits. J Aerosol Med, 3, S155–68.
  • Lippmann M. (2014). Toxicological and epidemiological studies of cardiovascular effects of ambient air fine particulate matter (PM2.5) and its chemical components: Coherence and public health implications. Crit Rev in Toxicol, (http://infomahealthcare.com/txc. ISSN: 1547-6898, electronic).
  • Lipworth L, La Vecchia C, Bosetti C, McLaughlin JK. (2009). Occupational exposure to rock wool and glass wool and risk of cancers of the lung and the head and neck: a systematic review and meta-analysis. J Occup Environ Med, 51, 1075–87.
  • Lockey JE, Roggli VL, Hilbert TJ, Rice CH, Levin L, Borton EK, et al. (2012). Biopersistence of refractory ceramic fiber in human lung tissue and a 20-year follow-up of radiographic pleural changes in workers. J Occup Environ Med, 54, 781–8.
  • Loomis D, Dement J, Richardson D, Wolf S. (2010). Asbestos fiber dimensions and lung cancer mortality among workers exposed to chrysotile. Occup Environ Med, 67, 580–4.
  • Luo S, Liu X, Mu S, Tsai SP, Wen CP. (2003). Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. Occup Environ Med, 60, 35–42.
  • Lynch KM, Smith WA. (1935). Pulmonary asbestosis: Carcinoma of lung in asbestosis-silicosis. Am J Cancer, 24, 56–64.
  • Magnani C, Terracini B, Ivaldi C, Botta M, Mancini A, Andrion A. (1995). Pleural malignant mesothelioma and nonoccupational exposure to asbestos in Castale Monferrato, Italy. Occup Environ Med, 52, 362–7.
  • Malmberg P, Hedenstein HJ, Kolmodin-Hedran B, Krantz S. (1984). Pulmonary function in workers of a mineral rock fibre plant. Biological effects of man-made mineral fibres. Proceedings of a WHO/IARC Conference, Vol. 1, April 20–22, 1982. Copenhagen, Denmark, pp. 427–35.
  • Markowitz SB, Levin SM, Miller A, Morabia A. (2013). Asbestos, asbestosis, smoking, and lung cancer. Am J Resp Crit Care Med, 188, 90–6.
  • Marsh GM, Youk AO, Stone RA, Buchanich JM, Gula MJ, Smith TJ, Quinn MM. (2001a). Historical cohort study of US man-made vitreous fiber production workers: I. 1992 Fiberglass cohort follow-up: Initial Findings. J Occp Environ Med, 43, 741–56.
  • Marsh GM, Buchanich JM, Youk AO. (2001b). Historical cohort study of US man-made vitreous fiber production workers: VI. Respiratory system cancer standardized mortality ratios adjusted for the confounding effect of cigarette smoking. J Occup Environ Med, 43, 803–8.
  • Marsh GM, Gula MJ, Youk AO, Buchanich JM, Churg A, Colby TV. (2001c). Historical cohort study of US man-made vitreous fiber production workers: II. Mortality from mesothelioma. J Occup Environ Med, 43, 757–66.
  • Mast RW, McConnell EE, Anderson R, Chevalier JC, Kotin P, Bernstein DM, et al. (1995). Studies on the chronic toxicity of (inhalation) of four types of refractory ceramic fiber in male Fisher 344 rats. Inhal Toxicol, 7, 425–67.
  • Maule MM, Magnani C, Dalmasso P, Mirabelli D, Merletti F, Biggeri A. (2007). Modeling mesothelioma risk associated with environmental asbestos exposure. Environ Health Perspect, 115, 1066–71.
  • Maxim LD, McConnell EE. (2005). A review of the toxicology and epidemiology of wollastonite. Inhal Toxicol, 17, 451–66.
  • McCaughey WTE, Wade OL, Elmes PC. (1962). Exposure to asbestos dust and diffuse pleural mesothelioma. Brit Med J, 2, 1397.
  • McClellan RO, Hesterberg TW. (1994). Role of biopersistence in the pathogenicity of man-made fibers and methods for evaluating biopersistence: a summary of two round-table discussions. Environ Health Perspect, 102, 277–83.
  • McClellan RO, Miller FJ, Hesterberg TW, Warheit DB, Bunn WB, Kane AB, et al. (1992). Approaches to evaluating the toxicity and carcinogenicity of man-made fibers: summary of a workshop held November 11–13, 1991, Durham, North Carolina. Regul Toxicol Pharmacol, 16, 321–64.
  • McConnochie K, Simonato L, Mavrides P, Christofides P, Pooley FD, Wagner JC. (1987). Mesothelioma in Cyprus: the role of tremolite. Thorax, 42, 342–7.
  • McConnell EE, Kamstrup O, Musselman RP, Hesterberg TW, Chevalier JC, Miller WC, Thevenaz P. (1994). Chronic inhalation study of size-separated rock and slag wool insulation fibers in fisher 344/N rats. Inhal Toxicol, 6, 571–614.
  • McConnell EE, Mast RW, Hesterberg TW, Chevalier J, Kotin P, Bernstein DM, et al. (1995). Chronic inhalation toxicity of a kaolin-based refractory ceramic fiber in Syrian golden hamsters. Inhal Toxicol, 7, 503–32.
  • McConnell EE, Axten C, Hesterberg TW, Chevalier J, Miller WC, Everitt J, et al. (1999). Studies of the inhalation toxicology of two fiberglasses and amosite asbestos in the Syrian golden hamster. Part II. Results of chronic exposure. Inhal Toxicol, 11, 785–835.
  • McCormack V, Peto J, Byrnes G, Stralf K, Boffetta P. (2012). Estimating the asbestos-related lung cancer burden from mesothelioma mortality. Brit J Cancer, 106, 575–84.
  • McDonald AD, Case BW, Churg A, Dufresne A, Gibbs GW, Sebastien P, McDonald JC. (1997). Mesothelioma in Quebec chrysotile miners and millers: epidemiology and aetiology. Ann Occup Hyg, 41, 707–19.
  • McDonald AD, Fry JS, Woolley GJ, McDonald JC. (1984). Dust exposure and mortality in an American chrysotile asbestos friction products plant. Br J Ind Med, 41, 151–7.
  • McDonald JC, McDonald AD, Armstrong B, Sebastien P. (1986). Cohort study of mortality of vermiculite miners exposed to tremolite. Occup Envion Med,43, 436–44.
  • McDonald JC, McDonald AD. (1997). Chrysotile, tremolite and carcinogenicity. Ann Occup Hyg, 41, 699–705.
  • McDonald JC, Harris J, Armstrong B. (2004). Mortality in a cohort of vermiculite miners exposed to fibrous amphibole in Libby MT. Occup Environ Med, 61, 363–6.
  • McDonald JC, Sébastien P, Case B, McDonald AD, Dufresne A. (1992). Ferruginous body counts in sputum as an index of past exposure to mineral fibres. Ann Occup Hyg, 36, 271–82.
  • McKay RT, LeMasters GK, Hilbert TJ, Levin LS, Rice CH, Lockey JE. (2011). A long-term study of pulmonary function among US refractory ceramic workers. J Occup Environ Med, 68, 89–95.
  • Meeker GP, Bern AM, Brownfield IK, Lowers HA, Sutley SJ, Hoefen TM, Vance JS. (2003). The composition and morphology of amphiboles from the Rainy Creek Complex, near Libby, Montana. Am Mineral, 88, 1955–69.
  • Merewether ERA, Price CW. (1930). Report on effects of asbestos dust on the lungs and dust suppression in the asbestos industry. His Majesty's Stationery Office.
  • Metintas S, Metintas M, Ucgun I, Oner U. (2002). Malignant melanoma due to exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest, 122, 2224–9.
  • Metintas S, Metintas M, Ak G, Kalyoncu C. (2012). Environmental asbestos exposure in rural Turkey and risk of lung cancer. Intl J Environ Health Res, 22, 468–79.
  • Meurman LO, Kiviluoto R, Hakama M. (1974). Mortality and morbidity among the working population of anthophyllite asbestos miners in Finland. Br J Ind Med, 31, 105–12.
  • Meurman LO, Kiviluoto R, Hakama M. (1979). Combined effects of asbestos exposure and tobacco smoking on Finnish anthophyllite miners and millers. Ann NY Acad Sci, 330, 491–5.
  • Miller BG, Searl A, Davis JMG, Donaldson K, Cullen RT, Bolton RE, et al. (1999a). Influence of fibre length, dissolution and biopersistence on the production of mesothelioma in the rat peritoneal cavity. Ann Occu. Hyg, 43, 155–66.
  • Miller BG, Jones AD, Searl A, Buchanan D, Cullen RT, Soutar CA, et al. (1999b). Influence of characteristics of inhaled fibres on development of tumours in the rat lung. Ann Occup Hyg, 43, 167–79.
  • Moalli PA, Macdonald J, Goodglick LA, Kane AB. (1987). Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am J Pathol, 128, 425–45.
  • Monchaux G, Bignon J, Jaurand MC, Lafuma JC, Sebastien P, Masse R, et al. (1981). Mesotheliomas in rats following inoculation with acid-leached chrysotile asbestos and other mineral fibers. Carcinogenesis, 2, 229–36.
  • Morgan A. (1979). Fiber dimensions: their significance in the deposition and clearance of inhaled fibrous dusts. In: Lemen R, Dement LM, Eds. Dusts and Disease Park Forest South, IL: Pathotox Publishers, pp. 87–96.
  • Morgan A, Black A, Evans N, Holme A, Pritchard JN. (1980). Deposition of sized glass fibers in the respiratory tract of the rat. Ann Occup Hyg, 23, 353–66.
  • Morgan A, Holmes A. (1984). The deposition of MMMF in the respiratory tract of the rat, their subsequent clearance, solubility in vivo and protein coating. In: Biological Effects of Man-Made Mineral Fibers, Vol. 2 Copenhagen: World Health Organization, pp. 1–17.
  • Morgan A, Holmes A, Davison W. (1982). Clearance of sized glass fibers from the rat lung and their solubility in vivo. Ann Occup Hyg, 25, 317–31.
  • Mossman BT, Craighead JE. (1987). Mechanisms of asbestos associated bronchogenic carcinoma. In: Antman K, Aisner J, Eds. Asbestos-Related Malignancy Orlando: Grune & Stratton, pp. 137–50.
  • Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, et al. (1990). Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis, 41, 1266–71.
  • Mossman GT, Bignon J, Corn M, Seaton A, Gee JBL. (1990). Asbestos: scientific developments and implications for public policy. Science, 247, 294–301.
  • Mossman BT, Lippmann M, Hesterberg TW, Kelsey KT, Barchowsky A, Bonner JC. (2011). Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev, 14, 76–121.
  • Muhle H, Bellmann B, Heinrich U. (1988). Overloading of lung clearance during chronic exposure of experimental animals to particles. Ann Occup Hyg, 32, 141–7.
  • Murphy FA, Schinwald A, Poland CA, Donaldson K. (2012). The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify proinflammatory response in mesothelioma cells. Part Fibre Toxicol, 9, 8–23.
  • Murphy FA, Poland CA, Duffin R, Donaldson K. (2013). Length-dependent pleural inflammation and parietal pleura responses after deposition of carbon nanotubes in the pulmonary airspaces of mice. Nanotoxicology, 6, 1152–67.
  • Musti M, Pollice A, Cavone D, Dragonieri S, Bilancia M. (2009). The relationship between malignant mesothelioma and an asbestos cement environmental risk: a spatial case-control in the city of Bari (Italy). Int Arch Occup Environ Health, 82, 489–97.
  • Newhouse ML, Thompson H. (1965). Epidemiology of mesothelial tumors in the London area. Ann NY Acad Sci, 132, 579–88.
  • Newhouse ML, Sullivan KR. (1989). A mortality study of workers manufacturing friction materials: 1941–86. Br J Ind Med, 46, 176–9.
  • Newhouse ML, Berry G, Skidmore JW. (1982). A mortality study of workers manufacturing friction materials with chrysotile asbestos. Ann Occup Hyg, 26, 899–909.
  • Nicholson WJ. (1986). Airborne Asbestos Health Assessment Update, United States Environmental Protection Agency, Office of Health and Environmental Assessment, Washington, DC, EPA/600/8–84/003F. Washington, DC: EPA.
  • NIOSH. (1977). Criteria for a Recommended Standard: Occupational Exposure to Fibrous Glass. Cincinnati, OH: National Institute for Occupational Safety and Health; Apr; DHHS (NIOSH) Publication Number 77–152.
  • NIOSH. (1979). USPHS/NIOSH Membrane Filter Method for Evaluating Airborne Asbestos Fibers. DHEW (NIOSH) Publication No. 79–127, 89pp.
  • NIOSH. (1986). Occupational Respiratory Diseases. Cincinnati, OH: National Institute for Occupational Safety and Health, Division of Respiratory Disease Studies; DHHS (NIOSH) Publication No. 86–102.
  • Nishimura SL, Broaddus VC. (1998). Asbestos-induced pleural disease. Clin Chest Med, 19, 311–29.
  • NRC. (1984). Asbestiform Fibers – Nonoccupational Health Risks. Washington, DC: National Academy Press.
  • NRC. (2000). Review of the U.S. Navy's Exposure Standard for Manufactured Vitreous Fibers. Washington, DC: National Academies Press
  • NTP. (2011). Certain glass wool fibers (inhalable). In: NTP. Report on Carcinogens. 12th ed. Research Triangle Park, NC: National Toxicology Program;http://www.ntp.niehs.nih.gov/ntp/roc/twelfth/profiles/GlassWoolFibers.pdf.
  • Oberdörster G, Morrow PE, Spurny K. (1988). Size dependent lymphatic short term clearance of amosite fibers in the lung. Ann Occup Hyg, 32, 149–56.
  • Oberdörster G. (2002). Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol, 14, 29–56.
  • Ogden TL. (2003). The 1968 BOHS chrysotile asbestos standard. Ann Occup Hyg, 47, 3–6.
  • OSTP. (1985). Office of Science and Technology Policy). Chemical carcinogens: a review of the science and its associated principles. Fed. Regist. II, 10371–10442. Fed Regist, 50:10371–442.
  • Osmond-McLeod MJ, Poland CA, Murphy F, Waddington L, Morris H, Hawkins SC, et al. (2011). Durability and inflammogenic impact of carbon nanotubes compared to asbestos fibers. Partic Fiber Toxicol, 8, 15–33.
  • Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. (2005). Residential Proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Resp Crit Care Med, 172, 1019–25.
  • Paustenbach DJ, Finley BI, Lu EI. (2004). Environmental and occupational health hazards associated with the presence of asbestos in brake linings and pads. J Toxicol Environ Health B Crit Rev, 7, 28–80.
  • Peto J, Doll R, Hermon C, Binns W, Clayton R, Goffe T. (1985). Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg, 29, 305–55.
  • Pierce JS, McKinley MA, Paustenbach DJ, Finley BL. (2008). An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma. Crit Rev Toxicol, 38, 191–214.
  • Pietruska JR, Johnston T, Zhitkovich A, Kane AB. (2010). XRCC1 deficiency sensitizes human lung epithelial cells to genotoxicity by crocidolite and Libby amphibole. Environ. Health Perspect, 118, 1707–13.
  • Pinkerton KE, Elliot AA, Frame SR, Warheit DB. (1997). Reversibility of fibrotic lesions in rats inhaling size-separated chrysotile asbestos fibres for 2 weeks. Ann Occup Hyg, 41, 178–83.
  • Poland A, Duffin R, Kinloch I, Maynard A, Wallace WAH, Seaton A, et al. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol, 3, 111–4.
  • Pooley FD. (1976). An examination of the fibrous mineral content of asbestos lung tissue from the Canadian chrysotile mining industry. Environ Res, 12, 281–98.
  • Pooley FD, Wagner JC. (1988). The significance of the selective retention of mineral dusts. Ann Occup Hyg, 32, 187–94.
  • Pooley FD, Clark NJ. (1980). A comparison of fibre dimension in chrysotile, crocidolite, and amosite particles from samples of airborne dust and from post-mortem lung tissue specimens. In: Wagner JC, Ed. Biological Effects of Mineral Fibres, Vol. 1 Lyons: International Agency for Research on Cancer, pp. 79–86.
  • Pott F, Friedrichs KH, Huth F. (1976). Results of animal experiments concerning the carcinogenic effect of fibrous dusts and their penetration with regard to the carcinogenesis in humans. Zentralbl Bakteriol Hyg, 162, 467–505.
  • Price B. (2010). Industrial grade talc exposure and the risk of mesothelioma. Crit Rev Toxicol, 40, 513–30.
  • Reid G, Keilkowski D, Steyn SD, Botha K. (1990). Mortality of an asbestos-exposed birth cohort: a pilot study. S Afr Med J, 78, 584–6.
  • Rodelsperger K, Bruckel B. (2006). The carcinogenicity of WHO fibers of silicon carbide: SiC whiskers compared to cleavage fragments of granular SiC. Inhal Toxicol, 18, 623–31.
  • Roggli VL, Brody AR. (1984). Changes in numbers and dimensions of chrysotile asbestos fibers in lungs of rats following short-term exposure. Exp Lung Res, 7, 133–47.
  • Roggli VL, George MH, Brody AR. (1987). Clearance and dimensional changes of crocidolite asbestos fibers isolated from lungs of rats following short-term exposure. Environ Res, 42, 94–105.
  • Rohs AM, Lockey JE, Dunning KK, Shukla R, Fan H, Hilbert T, et al. (2008). Low-level fiber-induced radiographic changes caused by Libby vermiculite: a 25-year follow-up study. Am J Respir Crit Care Med, 177, 630–7.
  • Roller M, Pott F, Kamino K, Althoff GH, Bellmann B. (1996). Results of current intraperitoneal carcinogenicity studies with mineral and vitreous fibres. Exp Toxicol Pathol, 48, 3–12.
  • Rossiter CF, Coles RM. (1980). H.M. Dockyard, Devonport: 1947 mortality study. In: Wagner JC, Ed. Biological Effects of Mineral Fibres, IARC Scientific Pub. No. 30, Lyons: International Agency for Research on Cancer, pp. 713–21.
  • Ryan PH, Dihle M, Griffin S, Partridge C, Hilbert TJ, Taylor R, et al. (2011). Erionite in road gravel associated with interstitial and pleural changes – an occupational hazard in western United States. J Occup Environ Med, 53, 892–8.
  • Sanchez MS, Gunter ME, Dyar MD. (2008). Characterization of historical amphibole samples from the former vermiculite mine near Libby, Montana., U.S.A. Eur J Mineral, 20, 1043–53.
  • Saracci R, Simonato L, Acheson ED, Anderson A, Bertazzi PA, Claude J, et al. (1984). Mortality and incidence of cancer of workers in the man-made vitreous fibres producing industry: An international investigation in 13 European plants. Br J Ind Med, 41, 425–36.
  • Sawyer RN. (1989). Asbestos material inventory, control concepts and risk communications. In: Symposium on Health Aspects of Exposure to Asbestos in Buildings Cambridge, MA: Harvard University Kennedy School of Government, pp. 155–69.
  • Sayers RR, Dreessen WC. (1939). Asbestosis. Am J Public Health, 29, 205–14.
  • Schinwald A, Murphy FA, Prina-Mello A, Poland CA, Byrne F, Movia D, et al. (2012a). The threshold length for fiber-induced acute pleural inflammation: shedding light on the early events in asbestos-induced mesothelioma. Toxicol Sci, 128, 461–70.
  • Schinwald A, Chernova T, Donaldson K. (2012b). Use of silver nanowires to determine threshold for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro. Part Fibre Toxicol, 9, 47–51.
  • Schlesinger RB, Lippmann M. (1978). Selective particle deposition and bronchogenic carcinoma. Environ Res, 15, 424–31.
  • Schlesinger RB, Concato J, Lippmann M. (1983). Particle deposition during exhalation: A study in replicate casts of the human upper tracheobronchial tree. In: Marple VA, and Liu BYH, Eds. Aerosols in the Mining and Industrial Work Environments, Vol. 1 Ann Arbor: Ann Arbor Science Publishers, pp. 165–76.
  • Schneider F, Sporn TA, Roggli VL. (2010). Asbestos fiber content of lungs with diffuse interstitial fibrosis. Arch Pathol Lab Med, 134, 457–61.
  • Scholze H, Conradt R. (1987). An in vitro study of the chemical durability of siliceous fibers. Ann Occup Hyg, 31, 683–92.
  • Sebastien P, Bignon J, Baris YL, Awad L, Petit G. (1984). Ferruginous bodies in sputum as an indication of exposure to airborne mineral fibers in the mesothelioma villages of Cappadocia. Arch Environ Health, 39, 18–23.
  • Sebastien P, Armstrong B, Case B, Barwick H, Keskula H, McDonald JC. (1988). Estimation of amphibole exposure from asbestos Body and macrophage counts in sputum: A survey in vermiculite miners. Ann Occup Hyg, 32, 195–201.
  • Seidman H, Selikoff IJ, Hammond EC. (1979). Short term asbestos work exposure and long term observation. Ann NY Acad Sci, 330, 61–90.
  • Selikoff IJ, Churg J, Hammond EC. (1964).). Asbestos exposure and neoplasia. JAMA, 188, 142–6.
  • Selikoff IJ, Hammond EC, Seidman H. (1979). Mortality experience of insulation workers in the United States and Canada: 1943–1976. Ann NY Acad Sci, 330, 91–116.
  • Selikoff IJ, Nicholson WJ, Langer AM. (1972). Asbestos air pollution. Arch Environ Health, 25, 1–13.
  • Shannon HS, Jamieson E, Julian JA, Muir DCF, Walsh C. (1987). Mortality experience of Ontario glass fiber workers – extended follow-up. Ann Occup Hyg, 31, 657–62.
  • Shannon H, Hayes M, Julian J, Muir D. (1984). Mortality experience of glass fibre workers. In: Biological Effects of Man-Made Mineral Fibers. Copenhagen: World Health Organization, pp. 347–9.
  • Shannahan JH, Nyska A, Cesta M, Schadweiler MCJ, Vallant BD, Ward WOI, et al. (2012). Subchronic pulmonary pathology, iron overload, and transcriptional activity after Libby amphibole exposure in rat models of cardiovascular disease. Environ Health Perspect, 120, 85–91.
  • Shukla A, Gulumian M, Hei TK, Kamp D, Rahman Q, Mossman BT. (2003). Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases. Free Radical Biol Med, 34, 1117–29.
  • Simonato L, Fletcher AC, Cherrie J, Andersen A, Bertazzi PA, Charney N, et al. (1986). Updating lung cancer mortality among a cohort of man-made mineral fibre production workers in seven European countries. Cancer Lett, 30, 189–200.
  • Smith AH, Wright CC. (1996). Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med, 30, 252–66.
  • Spengler JD, Ozkaynak H, McCarthy JF, Lee H. (1989). Summary of symposium on health aspects of exposure to asbestos in buildings. In: Symposium on Health Aspects of Exposure to Asbestos in Buildings, Cambridge, MA: Harvard University Kennedy School of Government, pp. 1–26.
  • Stanton MF, Wrench C. (1972). Mechanisms of mesothelioma induction with asbestos and fibrous glass. J Natl Cancer Inst, 48, 797–821.
  • Stanton MF, Layard M, Tegeris A, Miller E, May M, Kent E. (1977). Carcinogenicity of fibrous glass: Pleural response in the rat in relation to fiber dimension. J Natl Cancer Inst, 58, 587–603.
  • Stayner LT, Dankovic DA, Lemon RA. (1996). Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health, 86, 179–86.
  • Stöber W, Flachsbart H, Hochrainer D. (1970). Der aerodynamische Durchmesser von Latexaggregaten und Asbestfasern. Staub-Reinhalt Luft, 30, 277–85.
  • Stone RA, Youk AO, Marsh GM, Buchanich JM, Smith TJ. (2004). Historical cohort study of U.S. man-made vitreous fiber production workers IX: Summary of 1992 mortality follow up and analysis of respiratory system cancer among female workers. J Occup Environ Med, 46, 55–67.
  • Stone RA, Youk AO, Marsh GM, Buchanich JM, McHenry MB, Smith TJ. (2001). Historical cohort study of US man-made vitreous fiber production: IV. Quantitative exposure-response analysis of the nested case-control study of respiratory system cancer. J Occup Environ Med, 43, 779–92.
  • Su W-C, Cheng YS. (2006). Fiber deposition pattern in two human respiratory tract replicas. Inhal Toxicol, 18, 749–60.
  • Sussman RG, Cohen BS, Lippmann M. (1991a). Asbestos fiber deposition in a human tracheobronchial cast. I. Experimental. Inhal Toxicol, 3, 145–60.
  • Sussman RG, Cohen BS, Lippmann M. (1991b). Asbestos fiber deposition in a human tracheobronchial cast. II. Empirical model. Inhal Toxicol, 3, 161–79.
  • Timbrell V. (1972). An aerosol spectrometer and its applications. In: Mercer TT, Morrow PE, Stöber W, Eds. Assessment of Airborne Particles Springfield, IL: Charles C. Thomas, pp. 290–330.
  • Timbrell V. (1982). Deposition and retention of fibers in the human lung. Ann. Occup. Hyg, 26, 347–69.
  • Timbrell V. (1983). Fibers and carcinogenesis. J Occup Health Soc, 3, 3–12.
  • Timbrell V. (1984). Pulmonary deposition and retention of South African amphibole fibers: Identification of asbestosis-related measure of fiber concentration. In: Proceedings of VIth International Pneumoconiosis Conference, Bochum, 1983, Vol. 2. Geneva: ILO, pp. 998–1008.
  • Timbrell V, Ashcroft T, Goldstein B, Heyworth F, Meurman LO, Rendall REG, et al. (1987). Relationships between retained amphibole fibers and fibrosis in human lung tissue specimens. In: Walton WH, Ed. Inhaled Particles VI Oxford: Pergamon Press.
  • Tran CL, Jones AD, Cullen RT, Donaldson K. (1997). Overloading of clearance of particles and fibres. Ann Occup Hyg, 41, 237–243.
  • Trethowan WN, Burge PS, Rossiter CE, Harrington JM, Calvert IA. (1995). Study of the respiratory health of employees in seven European plants that manufacture ceramic fibres. Occup Environ Med, 52, 97–104.
  • Utidjian HMD, deTreville RTP. (1970). Fibrous glass manufacturing and health: Report of an epidemiological study. Parts I and II. Proceedings of the 35th Annual Meeting of the Industrial Health Foundation. October 13–14, 1970. Pittsburgh, PA. IHF Bulletin No. 44., pp. 98–102.
  • Veblen DR. (1980). Anthophyllite asbestos: Microstructures, intergrown sheet silicates and mechanisms of fiber formation. Am Mineral, 65, 1075–86.
  • Viallat JR, Rayhuad F, Passeral M, Boutin C. (1986). Pleural migration of chrysotile fibers after intratracheal injection in rats. Arch Environ Health, 41, 282–6.
  • Vincent JH, Johnston AM, Jones AD, Bolton RE, Addison J. (1985). Kinetics of deposition and clearance of inhaled mineral dusts during chronic exposure. Br J Ind Med, 42, 707–15.
  • Vincent JH. (1999). Particle Size-Selective Sampling for Particulate Air Contaminants. American Conference of Governmental Industrial Hygienists, Cincinnati, OH.
  • Wagner JC, Pooley FD. (1986). Mineral fibers and mesothelioma. Thorax, 41, 161–6.
  • Wagner JC, Skidmore JW. (1965). Asbestos dust deposition and retention in rats. Ann NY Acad Sci, 132, 77–86.
  • Wagner JC, Steggs A, Marchand P. (1960). Diffuse pleural mesothelioma and asbestos exposure in northwestern Cape Province. Br J Ind Med, 17, 260–71.
  • Wagner JC, Pooley FD, Barry G, Seal RME, Munday DE, Morgan J, Clark NJ. (1982). A pathological and mineralogical study of asbestos-related deaths in the United Kingdom. Ann Occup Hyg, 26, 417–22.
  • Wagner JC, Berry G, Skidmore JW. (1976). Studies of the carcinogenic effects of fiber glass of different diameters following intrapleural innoculation in experimental animals. In: Occupational Exposure to Fibrous Glass, HEW Publ. No. (NIOSH) 76–151, pp. 193–7.
  • Wagner JC, Berry G, Skidmore JW, Timbrell V. (1974). The effects of the inhalation of asbestos in rats. Br J Cancer, 29, 252–69.
  • Wagner JC, Skidmore JW, Hill RJ, Griffiths DW. (1985). Erionite exposure and mesotheliomas in rats. Br J Cancer, 51, 727–30.
  • Walker AM. (1984). Declining relative risks for lung cancer after cessation of asbestos exposure. J Occup Med, 2, 422–6.
  • Walton WH. (1982). The nature, hazards and assessment of occupational exposure to airborne asbestos dust: a review. Ann Occup Hyg, 25, 117–247.
  • Warheit DB, Hartsky MA. (1990). Species comparisons of alveolar deposition patterns of inhaled particles. Exp Lung Res, 16, 83–99.
  • Webber JS, Blake DJ, Ward TJ, Pfau JC. (2008). Separation and characterization of respirable amphibole fibers from Libby, Montana. Inhal Toxicol, 20, 733–40.
  • Weill D, Dhillon G, Freyder L, Lefante J, Glindmeyer H. (2011). Lung function, radiological changes and exposure: analysis of ATSDR data from Libby, MT, USA. Eur Resp J, 38, 376–83.
  • Weitzman SA, Graceffa P. (1984). Asbestos catalyzes hydroxyl and superoxide radical release from hydrogen peroxide. Arch Biochem Biophys, 288, 373–6.
  • Whittaker EJW, Zussman J. (1956). The characterization of serpentine minerals by X-ray diffraction. MinMag, 32, 107–15.
  • WHO. (1997). Determination of Airborne Fibre Number Concentrations. Geneva: World Health Organization, 53pp.
  • Wong O, Musselman RP. (1994). An epidemiological and toxicological evaluation of the carcinogenicity of man-made vitreous fiber, with a consideration of coexposures. J Environ Pathol Toxicol Oncol, 13, 169–80.
  • Wright GW, Kuschner M. (1977). The influence of varying lengths of glass and asbestos fibers on tissue response in guinea pigs. In: Walton WH, Ed. Inhaled Particles IV, Part 2. New York: Pergamon Press, pp. 455–72.
  • Yada K. (1967). Study of chrysotile asbestos by a high resolution electron microscope. Acta Crystallogr, 23, 704–7.
  • Yarborough CM. (2006). Chrysotile as a cause of mesothelioma: An assessment based on epidemiology. Crit Rev Toxicol, 36, 165–87.
  • Yu CP, Asgharian B, Abraham JL. (1990). Mathematical modeling of alveolar clearance of chrysotile asbestos fibers from the rat lings. J Aerosol Med, 21, 587–94.
  • Zalma R, Guignard J, Copin E, Pezzarat H. (1987). Studies of surface properties of asbestos. Env Res, 41, 296–301.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.